KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Cash from Financing Activities: 2010-2015

Historic Cash from Financing Activities for Biocryst Pharmaceuticals (BCRX) over the last 5 years, with Dec 2015 value amounting to $87,000.

  • Biocryst Pharmaceuticals' Cash from Financing Activities fell 75.90% to $87,000 in Q4 2015 from the same period last year, while for Dec 2015 it was $5.5 million, marking a year-over-year decrease of 95.10%. This contributed to the annual value of -$5.8 million for FY2024, which is 117.73% down from last year.
  • According to the latest figures from Q4 2015, Biocryst Pharmaceuticals' Cash from Financing Activities is $87,000, which was down 86.55% from $647,000 recorded in Q3 2015.
  • In the past 5 years, Biocryst Pharmaceuticals' Cash from Financing Activities registered a high of $105.8 million during Q2 2014, and its lowest value of -$773,000 during Q2 2011.
  • Moreover, its 3-year median value for Cash from Financing Activities was $2.7 million (2013), whereas its average is $12.3 million.
  • As far as peak fluctuations go, Biocryst Pharmaceuticals' Cash from Financing Activities tumbled by 462.81% in 2011, and later skyrocketed by 1,886.31% in 2014.
  • Over the past 5 years, Biocryst Pharmaceuticals' Cash from Financing Activities (Quarterly) stood at $679,000 in 2011, then crashed by 53.46% to $316,000 in 2012, then surged by 498.42% to $1.9 million in 2013, then plummeted by 80.91% to $361,000 in 2014, then tumbled by 75.90% to $87,000 in 2015.
  • Its Cash from Financing Activities stands at $87,000 for Q4 2015, versus $647,000 for Q3 2015 and $3.2 million for Q2 2015.